BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

Calyx Therapeutics

Calyx Therapeutics uses novel methods to isolate the biologically active molecule from natural plant and animal extracts with demonstrated clinical activity in humans. The company determines the chemical structure of the isolated compound and develops small-molecule analogs for pharmaceutical applications. Calyx is pursuing drug discovery efforts in the areas of diabetes, inflammation and allergy. Since its inception in 1997, Calyx has entered 2 compounds into clinical trials and has developed a rich pipeline of preclinical candidates in the areas of diabetes and inflammation.


Contact Details:
3513 Breakwater Avenue
Hayward
CA
94545
United States of America
Tel: 510.780.1020
Fax:510.780.1025
Email:info@calyxti.com
WWW:

www.calyxti.com/




Loading...

Recent Publications by Calyx Therapeutics:

Synthesis and structure-activity relationship studies of cinnamic acid-based novel thiazolidinedione antihyperglycemic agents.
A number of 2,4-thiazolidinedione derivatives of -phenyl substituted...
13th November, 2004
Department of Chemistry, Calyx Therapeutics Inc., 3513 Breakwater Avenue, Bioorg Med Chem. 2003 Sep 1;11(18):4059-67.
A novel peroxisome proliferator-activated gamma (PPAR gamma) agonist, CLX-0921, has potent antihyperglycemic activity with low adipogenic potential.
Agonists of the nuclear receptor peroxisome proliferator-activated...
26th September, 2003
Department of Biochemistry, Clinical Development, and Research Metabolism. 2003 Aug;52(8):1012-8.

BioNews Results for Calyx Therapeutics:

Archemix inks IP deal with Ribomic; Cytori to raise $17M;
FierceBiotech:  Aug 8 2008 5:26PM Matching: calyx therapeutics

Calyx Therapeutics Patents:

US Patent No.Title
6624197 Diphenylethylene compounds
6194453 Protein kinase inhibitor
6245814 Diphenylethylene compounds
6331633 Heterocyclic analogs of diphenylethylene compounds
6391854 Orally active fraction of momordica charantia, active peptides thereof, and their use in the treatment of diabetes

View more Calyx Therapeutics patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 227 times since April 2007, the link to the organisation's website has been followed 69 times

Search for more companies in Hayward

Search for more companies in CA



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Calyx Therapeutics
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.